Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Our Donors
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

Can a virtual AI platform make speech-language care more accessible for ALS?

Project Overview

Feasibility RCT of a digital tool for management of bulbar disease in ALS

Losing the ability to speak and swallow/eat are among the most devastating consequences of amyotrophic lateral sclerosis (ALS). Speech language pathology (SLP) clinicians are key specialists who support patients with bulbar ALS, providing means of tracking/monitoring the development of bulbar signs and symptoms and offering timely management recommendations. However, patients and caregivers face challenges accessing and receiving SLP services and/or feel unsatisfied with the quality of services provided. Various factors have been identified, including high caseloads, late referrals to SLP services, and a lack of efficient assessment and management tools.

To address these barriers to quality patient care, VirtualSLP was developed. It is an innovative artificial intelligence (AI) powered, remote, multimodal clinical management platform designed to streamline SLP clinical assessment and decision-making practices around bulbar symptom management using previously validated AI models. This platform will enable SLP clinicians to receive objective assessments in a timely manner and collaboratively develop an individualized management plan with patients and caregivers.

To date, all key modules of the VirtualSLP have been developed and individually tested. In the proposed research, our first aim is to examine the feasibility of incorporating the entire VirtualSLP platform within multidisciplinary ALS clinics through a randomized feasibility trial. We hypothesized that VirtualSLP will be well-received by both SLP clinicians and patients due to its accurate outputs (i.e., assessments and recommendations), streamlined workflow, and ease of use.

Our second aim is to establish the feasibility of conducting a randomized control trial to determine the effectiveness of VirtualSLP. This involves measuring trial recruitment rates, protocol adherence, and the accuracy of automated outcome measures (e.g., speaking rate, severity assessments). We expect strong recruitment and adherence rates. Additionally, we hypothesize that the automatic outcome measures will show a high correlation with clinical assessments made by SLPs.

Lastly, our third aim is to examine factors that influence the implementation of VirtualSLP. This includes investigating organizational, cultural, and individual-level facilitators and barriers perceived by SLP clinicians, patients, and caregivers. Characterizing these facilitators and barriers will help with the iterative updating of VirtualSLP, enhancing its features to better serve patients with bulbar ALS. The completion of the proposed research is crucial for paving the way for the full integration of VirtualSLP into daily SLP practice, thereby alleviating the barriers experienced by patients with bulbar ALS related to SLP services.

Principal Investigator

Jennifer Soriano , University of Toronto

Partners and Donors

ALS Society of Canada

Project Ongoing

Can a virtual AI platform make speech-language care more accessible for ALS?

  • Grant Type

    Capacity building grants

  • Area of research

    Neurodegeneration

  • Disease Area

    ALS

  • Competition

    2025 ALS Canada - Brain Canada Trainee Program

  • Province

    Ontario

  • Start Date

    2026

  • Total Grant Amount

    $165,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2026 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co